Blogs
On-Time Trials
Is High Turnover and Burnout in Clinical Research Fueling the Big Quit?
The “Big Quit” (aka the Great Resignation) is everywhere and certainly impacting clinical trials. The impact was felt over the last few years with forced lockdowns yet, when you look at clinicaltrials.gov a record 37K new studies were added in 2021 alone. ...
Failing Fast, why it should be embraced.
Only 13% of all clinical trials will be successful at bringing a product or device to market. However, if monitoring improves, we have demonstrated that: your chance for success increases and 2) in the event your trial might not succeed, On-Time...
Managing Staffing Difficulties in Clinical Trials
On-Time Trials’ CEO Trevor Coughlan recently attended the WCG MAGI conference in Philadelphia in May 2023. One of the recurring themes was Staffing and Retention and the burnout experienced by Clinical Research Associates. On-Time Trials has a solution...
Machine Learning in Clinical Trials Operations
Machine Learning in Clinical Trials Operations Introduction The demand for drug and device development is at an all-time high, with over 39,000 new trials launched in 2023, setting a new record. Despite this growth, the industry faces challenges...
Billy Taaffe – Joins On-Time Trials as Advisory Board Member
Billy Taaffe - Joins On-Time Trials as Advisory Board Member Austin, Texas 6/17/24 Press release On-Time Trials On-Time Trials, a leader in enhancing operational efficiencies in the clinical trials sector, is pleased to announce the appointment...